# Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction

> **NCT05168709** · PHASE4 · COMPLETED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 51 (actual)

## Conditions studied

- COVID-19
- Vaccine Reaction
- Immunization; Infection

## Interventions

- **BIOLOGICAL:** Tozinameran

## Key facts

- **NCT ID:** NCT05168709
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-20
- **Primary completion:** 2022-09-29
- **Final completion:** 2022-09-29
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05168709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05168709, "Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05168709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*